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Summary
Tumors are stiffer than normal tissue, and tumors have altered integrins. Because integrins are mechanotransducers that
regulate cell fate, we asked whether tissue stiffness could promote malignant behavior by modulating integrins. We found
that tumors are rigid because they have a stiff stroma and elevated Rho-dependent cytoskeletal tension that drives focal
adhesions, disrupts adherens junctions, perturbs tissue polarity, enhances growth, and hinders lumen formation. Matrix
stiffness perturbs epithelial morphogenesis by clustering integrins to enhance ERK activation and increase ROCK-gener-
ated contractility and focal adhesions. Contractile, EGF-transformed epithelia with elevated ERK and Rho activity could
be phenotypically reverted to tissues lacking focal adhesions if Rho-generated contractility or ERK activity was decreased.
Thus, ERK and Rho constitute part of an integrated mechanoregulatory circuit linking matrix stiffness to cytoskeletal
tension through integrins to regulate tissue phenotype.S I G N I F I C A N C E
By examining the significance of the relationship between tissue rigidity and tumor behavior at the molecular level, we showed that
tissue rigidity reflects matrix stiffening and elevated Rho GTPase-dependent cytoskeletal tension. We found that matrix stiffness
(exogenous force) and cytoskeletal tension (endogenous force) are functionally linked through ERK and ROCK and that they coop-
erate to modulate tissue behavior by regulating FA formation and GF signaling. Matrix stiffness influences tissue growth and morpho-
genesis by modulating cell contractility, and tensional homeostasis appears to be necessary for normal tissue behavior. These
findings provide a fresh perspective for appreciating the role of the tissue microenvironment in differentiation and tumorigenesis,
and for identifying tumor therapies.Introduction
Tumors are frequently detected through physical palpation as
a rigid mass residing within a compliant tissue. Indeed, screen-
ing for tumors by monitoring for tissue stiffness is widespread,
and strategies to image differences in tissue compliance have
been exploited for cancer screening (Khaled et al., 2004). Al-
though patients with fibrotic “stiff” lesions have a poor progno-
sis (Colpaert et al., 2001), the relationship between tissue rigid-
ity and tumor behavior at the molecular level is unclear.
Tumor rigidity likely reflects an elevation in interstitial tissue
pressure and solid stress due to a perturbed vasculature and
tumor expansion (Padera et al., 2004), an increase in the elastic
modulus of transformed cells mediated by an altered cytoar-
chitecture (Beil et al., 2003), and matrix stiffening linked to fi-
brosis (Paszek and Weaver, 2004). Tumor rigidity could influ-
ence treatment efficacy (Netti et al., 2000) and may enhance
tumor metastasis (Akiri et al., 2003). Whether tissue stiffness
could actively promote malignant transformation—and how it
could do so—have yet to be assessed.CANCER CELL : SEPTEMBER 2005 · VOL. 8 · COPYRIGHT © 2005 ELSEVIEExtracellular matrix (ECM) orientation mediates tension-
dependent cell migration to orchestrate developmental pro-
cesses such as gastrulation (Keller et al., 2003), and matrix
rigidity influences cell growth, viability, differentiation, and mo-
tility (Engler et al., 2004; Lo et al., 2000; Yeung et al., 2005).
Matrix compliance influences cell contractility (cytoskeletal
tension), Rho activity, and ERK-dependent growth (Wang et al.,
1998; Wozniak et al., 2003), and cytoskeletal tension promotes
growth (Roovers and Assoian, 2003) and focal adhesion (FA)
assembly (Burridge and Wennerberg, 2004). This suggests that
cell behavior, matrix stiffness, Rho, and cell contractility are
functionally linked. Consistently, Rho-dependent cytoskeletal
tension is implicated in branching morphogenesis (Moore et
al., 2002), and ROCK disrupts adherens junctions (AJs) (Sahai
and Marshall, 2002). Three-dimensional (3D) culture studies
emphasize the importance of matrix compliance for normal tis-
sue differentiation (Paszek and Weaver, 2004) and imply that
matrix stiffness regulates cell fate by modulating growth factor
(GF) signaling and Rho GTPase function (O’Brien et al., 2001;
Wang et al., 1998). Indeed, Rho activity is often elevated inR INC. DOI 10.1016/j.ccr.2005.08.010 241
A R T I C L EFigure 1. Matrix rigidity regulates growth, mor-
phogenesis, and integrin adhesions
A: Top right: phase images and H&E-stained tis-
sue showing typical morphology of a mammary
gland duct in a compliant gland (167 Pa), com-
pared with MEC colonies grown in BM/COL I
gels of increasing stiffness (170–1200 Pa). Bot-
tom: confocal immunofluorescence (IF) images
of tissue section of a mammary duct and cryo-
sections of MEC colonies grown as above,
stained for β-catenin (green), α6 or β4 integrin
(red), and nuclei (blue).
B: Colony size of MECs grown as described in A.
***p % 0.001.
C: Elastic modulus of normal mouse mammary
gland and established tumors from MMTV-Her2/
neu, Myc, and Ras transgenic mice; average
value for tumor-adjacent stroma, compared
with BM and COL gels; and typical glass and
polystyrene substrates used for monolayer cul-
ture. Values represent the mean ± SEM of four
measurements from multiple mice and gels.
**p % 0.01.
D: Confocal IF images of β1 integrin adhesions
(green) in MECs in BM/COL I gels of 175 and
1200 Pa for 16 days (3D BM; soft versus stiff), or
70% confluent monolayers on BM-coated poly-
styrene (2D stiff), costained for FAKpY397,
FAKpY861, vinculin (red), or actin (red) and nuclei
(blue). An enlargement of this panel is included
in the Supplemental Data.
E: Confocal IF images of FAKpY397, vinculin (red),
and nuclei (blue) in MECs in normal and tumor
mouse mammary tissue.“stiff” tumors (Fritz et al., 1999), and activating ROCK induces
tumor dissemination (Croft et al., 2004). Therefore, tissue stiff-
ening could drive transformation by increasing Rho-generated
cytoskeletal tension.
Integrins are transmembrane ECM receptors that can func-
tion as mechanotransducers (Bershadsky et al., 2003), inte-
grins regulate Rho- and GF-ERK-dependent growth (Lee and
Juliano, 2004), and ERK influences ROCK and myosin activity
(Huang et al., 2004; Vial et al., 2003). Exogenous force can
activate integrins (Tzima et al., 2001), drive adhesion assembly
(Galbraith et al., 2002), and influence FA formation (Riveline et
al., 2001). Moreover, Rho-generated cytoskeletal tension pro-
motes FA assembly and drives ERK-dependent growth (Chrza-
nowska-Wodnicka and Burridge, 1996), and cytoskeletal rein-242forcement of integrins is required for FAKpY397 phosphorylation
(Shi and Boettiger, 2003). Furthermore, integrin expression is
higher in epithelia on rigid two-dimensional (2D) substrata than
on a compliant 3D matrix (Delcommenne and Streuli, 1995),
and matrix rigidity increases integrin expression (Yeung et al.,
2005). Thus, tissue stiffness could drive expression of a malig-
nant phenotype through force-dependent regulation of integrin
expression, activity, or adhesions. Indeed, integrin levels and
signaling are altered in “stiff” tumors (Guo and Giancotti, 2004),
and integrins and Rho GTPases can modify the tumorigenic
behavior of a tissue (Liu et al., 2004; White et al., 2004). Here,
we asked if and how tissue stiffening could drive malignant
behavior of a tissue through Rho-dependent integrin modu-
lation.CANCER CELL : SEPTEMBER 2005
A R T I C L EFigure 2. Matrix stiffness modulates integrin ad-
hesions to regulate MEC growth and behavior
A: Cell area for MECs on soft and stiff BM-cross-
linked PA gels.
B: Colony size of MEC spheroids on BM gels of
increasing stiffness (150–5000 Pa), overlaid with
BM to induce morphogenesis (3D BM gel).
C: Phase contrast microscopy and confocal IF
images of MEC colonies on 3D BM gels of
increasing stiffness (150–5000 Pa), showing col-
ony morphology after 20 days (top); β-catenin
before (large image) and after triton extraction
(inset; see also Supplemental Data) (green),
costained with β4 integrin (large image) or
E-cadherin (inset) (red; middle); and actin
(green), costained with LN-5 (BM; red; bottom)
and nuclei (blue).
D: Confocal IF images of β1 integrin adhesions
(green) in MECs on soft and stiff BM gels (400
versus 5000 Pa), costained for FAKpY397, FAKpY861,
talin, vinculin (red), actin (red), and nuclei
(blue). Inset: 3× magnification. An enlargement
of this panel is included in the Supplemental
Data.
E: Representative immunoblot of total and
phospho-FAK and E-cadherin in MECs on soft
and stiff BM gels.
F: Quantification of E-cadherin-normalized FAK
immunoblot results shown in E.
G: Immunoblot analysis of Src family kinases and
E-cadherin in MECs on soft and stiff BM gels.
H: Left: confocal IF images of activated β1 inte-
grin (red; HUTS-4), costained with total β1 inte-
grin (green) and nuclei (blue). Right: represen-
tative immunoblot of ligand bound β1 integrin
(HUTS-21 binding) in MECs on soft and stiff BM
gels.
I: Graph showing immunoblot quantification of
EGF-induced (20 ng/ml) phospho-ERK normal-
ized to E-cadherin in MECs on soft and stiff BM
gels for 4 days.
A and B represent z400 measurements from
three experiments. A, B, F, and I are mean ± SEM
of three experiments. Cells in A, D, E, G, and H
were on gels for 24 hr. *p % 0.05; ***p % 0.001.Results
Matrix rigidity regulates growth, morphogenesis,
and integrin adhesions
The mammary gland develops within a fat pad and represents
one of the more compliant tissues in the body (Figure 1A). We
reasoned that mammary differentiation and tissue homeostasis
would be most favored by a soft tissue microenvironment and
that breast desmoplasia and tissue stiffening that accompany
mammary tumor development might therefore actively promote
malignant behavior of the gland (Azar et al., 2001). To test this
possibility, an electro-mechanical indentor was used to con-
duct unconfined compression analysis of normal and ma-
lignant breast tissues from MMTV-Her2/neu, Myc, and Ras
transgenic mice. Normal mammary tissue was found to be ex-
tremely soft, whereas the stromal matrix adjacent to the trans-CANCER CELL : SEPTEMBER 2005formed cells and the tumor itself was quite stiff (Figure 1C).
Reconstituted ECMs, such as 1 mg/ml collagen (COL) gels and
basement membrane (BM) gels, that support normal mammary
tissue morphogenesis in culture were also very soft, with elastic
moduli virtually identical to normal mammary tissue. COL gels
used to study branching morphogenesis had an intermediate
stiffness, and gels and substrata that do not support normal tis-
sue morphogenesis such as polystyrene (tissue culture plastic)
and soda lime glass were exceedingly rigid (Callister, 2000).
To explore the role of matrix stiffness in mammary tissue be-
havior, BM/COL I gels were produced with constant BM (to
permit laminin [LN]-dependent acini morphogenesis), and the
COL levels were varied to recapitulate the range of stiffness
between normal mammary gland and tumors. When BM/COL
compliance was matched to that of a normal mammary stroma
(compare 167 to 170 Pa), nonmalignant MCF10A (Figures 1A243
A R T I C L EFigure 3. Matrix rigidity regulates cell behavior
by inducing FAs
A: Cell spreading quantified as cell area for fi-
broblasts on soft and stiff FN gels. Values repre-
sent z400 measurements from three experi-
ments. ***p % 0.001.
B: Confocal IF images of α5(β1) integrin adhe-
sions (green) in fibroblasts on soft and stiff FN
gels (400 versus 5000 Pa) costained for FAKpY397,
FAKpY861, talin, vinculin (red), actin (red), and
nuclei (blue). An enlargement of this panel is in-
cluded in the Supplemental Data.
C: Representative immunoblot of total and
phospho-FAK protein in fibroblasts on soft and
stiff FN gels.
D: Quantification of immunoblot results shown
in C.
E: Relative fibroblast adhesion on soft and stiff
FN gels.
F: Quantification of shear force required to de-
tach fibroblasts from soft (1050 Pa) and stiff (66
kPa) FN gels.
G: Confocal IF images of FAKpY397 (red), EGFP
(inset; green), and nuclei (blue) in fibroblasts ex-
pressing exogenous EGFP vector (Vector), wild-
type β1 integrin, and EGFP vector (β1 WT), or a
constitutively activated β1 glycan wedge
G429N integrin and EGFP vector (Activation Mu-
tant) on a soft FN gel, compared to fibroblasts
expressing EGFP vector (Vector) on a stiff FN gel.
H: Confocal IF images of α5(β1) integrin (EGFP;
green) in fibroblasts on soft and stiff FN gels.
**p % 0.01.
I: Summary of experimental results from Figures
1–3. Regardless of cell or matrix type, cells in-
teracting with a soft matrix assemble focal com-
plexes and express high amounts of total and
active Src family kinase, whereas on a stiff mat-
rix cells spread and assemble stress fibers, acti-
vate more ERK in response to growth factors,
and form FAs with FAKpY397 and vinculin.
Experiments reported for D–F and H are mean ±
SEM of three experiments.and 1B) and HMT3522 S-1 MECs (data not shown) formed
small growth-arrested and polarized acini with AJs and a
central lumen (compare tissue acinus to acini formed in a 1
mg/ml floating BM/COL gel). Yet, even a small increase in mat-
rix stiffness (170–1200 Pa) significantly increased EGF-depen-
dent growth (Figure 1B), compromised tissue organization, in-
hibited lumen formation, and destabilized AJs (indicated by
diffuse β-catenin [Figure 1A] and triton-extractable and nonco-
localized β-catenin and E-cadherin [data not shown]). Interest-
ingly, disruption of basal polarity, visualized by diffuse β4 inte-
grin localization, required a substantial increase in matrix
rigidity (compare 170 to 1200 Pa; Figure 1A).
Because integrins are mechanotransducers that relay ECM
cues, the effect of matrix stiffness on integrin function was ana-
lyzed by assessing colocalization of components involved in244mechanosignaling with (α3)β1 integrin. MECs interacting in 3D
with a soft (175 Pa) and stiff (1200 Pa) BM, and in 2D with a
stiff BM (1–2 GPa), formed (α3)β1 integrin adhesions, indicated
by FAKpY861 (Figure 1D) and talin (data not shown) that coloca-
lized with β1 integrin. However, MECs could only phosphory-
late FAKpY397 and recruit vinculin to their (α3)β1 integrin adhe-
sions when interacting in 2D or 3D with a rigid BM (Figure 1D).
These data indicate that a stiff matrix, whether in 2D or 3D, is
incompatible with normal tissue morphogenesis and that mat-
rix stiffness may modulate integrin adhesions. Because a sim-
ilar correlation between tissue stiffness and FAKpY397 and vin-
culin expression in normal and malignant tissues in vivo was
also observed (Figure 1E), this suggests that tissue stiffness
could contribute to aberrant epithelial tissue behavior by influ-
encing integrin adhesions.CANCER CELL : SEPTEMBER 2005
A R T I C L EMatrix stiffness modulates integrin adhesions to regulate
MEC growth and behavior
COL gels are inherently variable, and elevating matrix stiffness
by increasing COL concentration could confound data inter-
pretation through altered integrin occupancy. To address this,
we used BM-crosslinked polyacrylamide (PA) gels (BM gel)
with calibrated elastic moduli of 150, 400, 675, 1050, and
R5000 Pa. Similar to MECs inside a 3D BM (3D BM; Weaver
et al., 2002) or on top of a thick BM overlaid with BM (3D over
BM; Debnath et al., 2003), by 16–20 days MECs on a compliant
PA BM gel overlaid with BM (3D BM gel) formed growth-
arrested acini with cell-cell localized β-catenin, basally polar-
ized β4 integrin, and apical-lateral cortical actin and assembled
an endogenous LN-5 BM (Figure 2C). Similar to results with 3D
COL gels, increasing matrix rigidity (from 150 to 400 to 675 to
1050) progressively increased EGF-dependent ERK activationFigure 4. Force-dependent integrin aggrega-
tion, FAs, and cell behavior
A: Correlation between matrix rigidity, fibroblast
area, and fibroblast contractility (quantified by
TFM).
B: Representative traction map showing typical
force distribution in fibroblasts on soft (450 Pa)
and stiff FN gels (5600 Pa).
C: Confocal IF images showing time course of
changes in α5β1 integrin (green), FAKpY397 (red),
and nuclei (blue) in fibroblasts on soft FN gels
before (Soft; Control) and after (Soft; 5 and 35
min) 140 dynes shear force. An enlargement of
this panel is included in the Supplemental Data.
D: Adhesion size in fibroblasts on soft FN gels be-
fore (Control) and after (5 min) shear force, and
additional incubation.
E: Graph showing no change in fibroblast
spreading 5 min after 140 dynes shear force, but
a significant increase after 30 min incubation
(35 min).
F: Bar graph showing increased FAKpY397 relative
to total FAK in fibroblasts on soft FN gels after
140 dynes shear stress (5 min) and 30 min incu-
bation (35 min).
G: Model of force-dependent FA assembly.CANCER CELL : SEPTEMBER 2005and colony size (Figures 2B and 2I), hindered lumen formation,
destabilized AJs, and perturbed tissue polarity (absence of
β-catenin/E-cadherin colocalization and triton-extractable
β-catenin [Figure 2C and inset], disrupted localization of β4 in-
tegrin and LN-5, and progressive filling of the spheroid lumens;
Figure 2C). Intriguingly, actin stress fibers were not observed in
any of these cultures until matrix rigidity increased to 5000 Pa,
toward that measured in tumors (z4049 Pa) and in MECs on
highly rigid 2D substrata (1–2 GPa; Figures 1 and 2D, phalloidin).
Because MEC colonies initiate clonally, the effect of matrix
compliance on MEC behavior and integrin adhesions in iso-
lated cells was examined. Within 12 hr of plating, MECs spread
significantly more on stiff versus soft BM gels (Figure 2A). Yet,
MECs adhered rapidly, activated β1 integrin (Figure 2H), and
recruited talin and FAKpY861 to β1 integrin adhesions (Figures
2D–2F) equally on soft and stiff BM gels, indicating that MECs245
A R T I C L EFigure 5. Integrin clustering enhances ERK activation and cell contractility to perturb tissue behavior
A: Bottom right: alignment of the C-terminal 82 amino acids of the human β3 and β1 integrin with incorporated amino acid substitutions indicated. Bottom
left: a helical wheel representing the β1 integrin transmembrane domain indicating that V737 and G744 lie on the same face of the helix separated by
two turns.
B: Confocal IF images of α3 integrin (red; top left), EGFP-tagged wild-type, and mutant β1 integrin (EGFP; green; top right), with α3 and β1 integrin overlay
(yellow; bottom).
C: Adhesion size in MECs expressing the EGFP vector (Vector), EGFP-tagged wild-type (β1 WT), and V737N β1 integrin (β1 V737N).
D: Confocal IF vertical image showing aggregates of β1 integrin in MECs expressing the V737N mutant (green), compared to MECs expressing wild-type
β1 integrin.
E: Cell area of MECs on soft BM gels expressing EGFP vector (Vector), EGFP-tagged wild-type β1 integrin (β1 WT), or V737N β1 integrin (β1 V737N).
F: Bar graph of force exerted by cells on soft gels expressing V737N β1 integrin (Tet−; β1 V737N) compared to tetracycline-treated controls (Tet+; control).246 CANCER CELL : SEPTEMBER 2005
A R T I C L Ecould assemble integrin adhesions under both conditions. In-
deed, MECs on soft BM gels had higher levels of total and
activated LynpY507 and LckpY505 kinases than MECs on stiff
gels (Figure 2G), and MECs grew and survived in 3D quite well,
consistent with integrin activation, FAKpY861, and adhesion as-
sembly (Arias-Salgado et al., 2003). Because cells suspended
in the absence of ECM also lacked FAKpY861 and FAKpY397,
but could phosphorylate FAKpY861 upon antibody-induced or
polymerized ligand-mediated integrin clustering (Supplemental
Data; Shi and Boettiger, 2003), this suggests that MECs on soft
BM gels likely assemble focal complexes as opposed to FAs.
Indeed, only MECs interacting with a stiff BM gel, or a stiff
tissue stroma, could phosphorylate FAKpY397 and recruit vin-
culin to (α3)β1 integrin adhesions (Figures 1D, 1E, and 2D–2F),
suggesting that matrix stiffness is necessary for FA assembly
or stabilization. Consistently, MECs on stiff gels activated and
sustained more ERK and grew better in response to EGF (Fig-
ure 2I), comparable to fibroblasts on a rigid fibronectin (FN)
substrate that sustain ERK activity only when FAs are present
(Roovers and Assoian, 2003).
Matrix rigidity regulates cell behavior by inducing FAs
To understand how ECM rigidity could regulate integrin adhe-
sions, the effect of matrix compliance on α5β1 integrin-FN ad-
hesions and fibroblast behavior was also assessed. Identical
to MECs on BM gels, fibroblasts on soft and stiff FN-cross-
linked PA gels (FN gel) adhered and recruited talin and
FAKpY861 comparably at α5β1 integrin adhesions (Figure 3B).
Moreover, only fibroblasts interacting with a stiff FN gel assem-
bled actin stress fibers, phosphorylated FAKpY397, and re-
cruited vinculin to α5β1 integrin adhesions (Figures 3B–3D). Fi-
broblasts also spread significantly better on stiff versus soft FN
gels (Figure 3A). Interestingly, fibroblasts adhered equally to
soft and stiff FN gels (Figure 3E), and when adhesion strength
was measured using a spinning disc apparatus (Shi and Boet-
tiger, 2003) fibroblasts detached with virtually the same force
per cm2 from soft and stiff FN gels (Figure 3F), suggesting that
they adhere with the same strength regardless of matrix com-
pliance. Consistently, ectopic expression of neither wild-type
α5 integrin (Yeung et al., 2005), nor wild-type β1 integrin (Figure
3G), nor even a constitutively active G429N β1 integrin glycan
wedge mutant (Luo et al., 2004) could increase FAKpY397 or
drive fibroblast spreading on a soft FN gel. Instead, α5β1 inte-
grin adhesions were much larger in fibroblasts spread on stiff
FN gels (Figure 3H), implying that cells on compliant gels form
focal complexes and that a stiff matrix alters cell behavior by
promoting FAs (Figure 3I).
Force-dependent integrin aggregation,
FAs, and cell behavior
FAKpY397 and vinculin recruitment to integrin adhesions re-
quires force (Galbraith et al., 2002; Shi and Boettiger, 2003),G: Phase contrast and confocal images of activated β1 integrin (HUTS-4), β4 integrin, β-catenin, LN-5, and FAKpY397 (red) in MEC colonies expressing EGFP-
tagged wild-type β1 integrin (β1 WT), compared to the EGFP-tagged V737N β1 integrin (β1V737N), with and without the MEK inhibitor U0126, after 16 days
in BM. Inset: 2× magnification.
H: Quantification of immunoblot results of EGF-dependent (20 ng/ml) phospho-ERK activity normalized to E-cadherin in wild-type β1 integrin and β1V737N-
expressing MECs on soft BM gels for 24 hr.
I: Colony size of MECs expressing the EGFP-tagged wild-type β1 integrin (β1 WT) or V737N β1 integrin (β1 V737N) treated with or without U0126 for 16 days
in BM.
C, E, F, and H are mean ± SEM of three experiments, and E, F, and H consist of z400 measurements. *p % 0.05; **p % 0.01; ***p % 0.001.
pletely cleared lumens; Figures 5G and 5I), but the abnormalCANCER CELL : SEPTEMBER 2005matrix stiffness modulates cell contractility (Wang et al., 2000),
and Rho-induced cytoskeletal tension clusters integrins (Chr-
zanowska-Wodnicka and Burridge, 1996). Consistently, traction
force microscopy (TFM) showed that contractility (integral of
the force magnitudes), cell spreading (cell area), and FAKpY397
(data not shown) positively correlate with matrix rigidity (Fig-
ures 4A and 4B), confirming that force is likely required for FA
assembly and/or stabilization. To directly test this prediction,
fibroblasts on soft FN gels were subjected to an exogenous
shear force, and a correlation between force magnitude and
the timing of the appearance of FAs and cell spreading was
assessed. A 5 min shear force of 100–140 dynes was sufficient
to increase the size of α5β1 integrin adhesions and induce
FAKpY397 and cell spreading (Figures 4C–4F). Yet, integrin clus-
tering preceded rather than followed the appearance of
FAKpY397 and cell spreading (lag time 20–30 min; Figures 4C–
4F), implying that force-dependent integrin aggregation (an-
isotropy) promotes FA assembly (Nicolas et al., 2004).
Integrin clustering enhances ERK activation and induces
cell tension to perturb tissue behavior
Because force-dependent integrin aggregation preceded FA
assembly, β1 integrin mutants with increased transmembrane
molecular associations were generated to test whether integrin
anisotropy could drive FA formation. Hydrophobic valine 737
was replaced with hydrophilic asparagine (V737N), or neutral
glycine 744 was replaced with asparagine (G744N), to promote
integrin self-association through enhanced hydrogen bonding
in the transmembrane domain (Li et al., 2003), and cells ex-
pressing the mutant integrins were assayed for their behavior
on compliant gels. Untagged (data not shown) and EGFP-
tagged wild-type and mutant V737N (Figure 5B) and G744N
(data not shown) β1 integrin expressed equally well in MECs
and fibroblasts (data not shown), colocalized with integrins at
sites of matrix adhesion (Figure 5B), adhered similarly (data not
shown), and had comparable levels of cell surface β1 and β4
integrin (data not shown) and ligand bound integrin (Supple-
mental Data). Enhancing integrin associations did not induce
integrin clustering when cells were plated on a rigid matrix
(e.g., tissue culture plastic; Luo et al., 2005); however, on soft
gels (analogous to cells in suspension with no tension; Li et al.,
2003), V737N β1 integrin-expressing cells spread significantly
more (Figures 5D and 5E), formed larger integrin adhesions
(Figures 5C and 5D) with more FAKpY397 (Figure 5G), and acti-
vated more ERK in response to GF stimulation (Figure 5H).
V737N β1 integrin-expressing cells exerted greater force (Fig-
ure 5F), and V737N β1 integrin-expressing MECs exhibited ab-
errant morphogenetic behavior, in response to a compliant ma-
trix (V737N β1 integrin MECs formed larger, nonpolarized
colonies lacking AJs and assembled spheroids lacking a com-247
A R T I C L Ephenotype could be phenotypically reverted if ERK activity was
repressed (Figures 5G and 5I). These data extend previous
work highlighting the existence of a functional link between cy-
toskeletal tension-regulated FA assembly and ERK-dependent
growth to show that matrix compliance (exogenous force) can
influence tissue phenotype by regulating integrin aggregation
to enhance GF-dependent ERK activation, induce cell tension
(endogenous force), and drive or stabilize FA assembly.
Matrix stiffness induces integrin clustering to enhance
GF-dependent ERK activation and Rho-generated force,
thereby modifying tissue growth and morphology
Integrins regulate Rho GTPases, cells employ myosins for con-
tractility, and myosin activity is regulated by Rho (Burridge and
Wennerberg, 2004). We found that matrix rigidity increases Rho
activity (Figure 6B), and inhibiting ROCK using Y-27632, or my-
osins using ML-7 or Blebbistatin (data not shown), significantly
reduces cell-generated force (Figure 6A). Moreover, expressing
a constitutively active V14Rho elevates cell-generated force
(Figure 6C), increases the number and size of FAs (Figure 6E),
and significantly increases cell spreading on a soft gel (Figures
6D and 6E). V14Rho also increases the size of EGF-dependent
mammary colonies in BM (Figure 6G), increases FAs (see vin-
culin and FAKpY397; Figure 6F), and compromises MEC mor-
phogenesis (diffuse β-catenin and absence of cleared lumens;
Figure 6F). Nevertheless, the aberrant V14Rho tissue pheno-
type could be phenotypically normalized by inhibiting EGF-
dependent ERK activation (using the U0126 MEK inhibitor) or
by inhibiting cell contractility (using a myosin II inhibitor, Bleb-
bistatin), and ERK inhibition decreased cytoskeletal tension
(endogenous force) and reduced ROCK levels (Figures 6H and
6I; see also Supplemental Data). This indicates that matrix
compliance (exogenous force)-dependent integrin clustering
regulates GF-dependent ERK activation to control cell growth
and tissue behavior by influencing Rho-generated cytoskeletal
tension and FA formation.
GF signaling, Rho-dependent tension, FAs,
and the malignant phenotype
Similar to primary normal and malignant MECs, nonmalignant
EGF-dependent S-1 MECs from the HMT3522 tumor pro-
gression series assemble acini in BM, whereas their EGFR-
transformed T4-2 progeny form continuously growing, disorga-
nized, and invasive colonies (Figure 7F, compare S-1 to T4-2).
Yet, these T4-2s, which form abundant FAs (Figure 7B) and
have elevated EGF-dependent ERK activity, can be phenotypi-
cally reverted to form polarized and growth-arrested acini if β1
integrin, EGFR, or ERK activity is inhibited (Wang et al., 1998).
Consistent with a model in which an ECM compliance (exoge-
nous force)-integrin-GF-ERK-Rho signaling circuit links cy-
toskeletal tension to cell growth and tissue phenotype, T4-2s
spread more (Figure 7E) and exert significantly higher force on
a soft BM gel, as compared to S-1s (Figures 7C and 7D). T4-
2s also have higher Rho activity (Figure 7A), and inhibiting Rho
or myosin activity by expressing a dominant-negative N19Rho
(Figure 7B; green inset), or by treatment with Y-27632 or Bleb-
bistatin, significantly represses T4-2 contractility and cell
spreading (compare T4-2s to N19Rho, Y-27632, and Blebbi-
statin T4-2s; Figures 7B–7D). Reducing Rho-ROCK-dependent
cytoskeletal tension in these mammary tumors also reduces
FAKpY397, reestablishes tissue polarity (basal β4 integrin and248LN-5), restores cell-cell interactions (less diffuse β-catenin),
permits lumen formation, and reduces colony size (Figures 7B,
7F, and 7G). Normalizing tumor cytoskeletal tension also re-
duces ROCK expression and ERK activity (Figure 7J) and
lowers total and activated EGFR (Figure 7I), which could ex-
plain the significant reduction in proliferation and cytoskeletal
tension also observed (Figures 7C, 7D, and 7H). Thus, although
in tumors integrin and GF-dependent ERK activation can be-
come uncoupled from exogenous force cues (matrix stiffness),
some transformed cells do retain functional links between cy-
toskeletal tension and Rho signaling, such that normalizing
mechanosignaling can repress their malignant phenotype.
Discussion
Tissue stiffness can predict the presence of a tumor or the de-
velopment of pathology with a heightened risk of malignant
transformation, yet the relevance of tissue rigidity to tumor
pathogenesis has been largely ignored. We showed that tumor
rigidity reflects an increase in stromal stiffness and tumor cell
tension. We found that even a small increase in matrix rigidity
will perturb tissue architecture and enhance growth by induc-
ing Rho-generated cytoskeletal tension to promote FA assem-
bly and increase GF-dependent ERK activation. We deter-
mined that a highly contractile, EGFR-transformed epithelium
with elevated Rho and ERK activity can be phenotypically re-
verted to form differentiated acini lacking FAs with reduced
EGFR activity if Rho-generated cytoskeletal tension or ERK ac-
tivity is decreased. Accordingly, these data underscore the po-
tential existence of a mechanoregulatory circuit that functions
to integrate physical cues from the ECM (exogenous force) with
FA assembly through ERK- and Rho-dependent cytoskeletal
contractility to regulate cell and tissue phenotype (Figure 8).
Thus, tensional homeostasis may be essential for normal tissue
growth and differentiation, and increasing tissue rigidity by
stiffening the matrix (fibrosis) or by elevating Rho signaling
through, for example, oncogene (Ras)-driven ERK activation,
could induce cytoskeletal contractility to enhance integrin-
dependent growth and destabilize tissue architecture (Zhong
et al., 1997). As such, conditions that induce tissue fibrosis
(matrix stiffening; Akiri et al., 2003) or situations that amplify
oncogene activity to enhance ERK could facilitate malignant
transformation by increasing cell contractility through Rho. Be-
cause we found that transformed cells can retain a functional
link between Rho-dependent cytoskeletal tension, integrins,
and growth regulation, pharmacological inhibitors that target
ROCK, ERK, or integrin adhesions could temper the malignant
behavior of some tumors by normalizing activity through the
cellular mechanocircuitry.
Pertinent to the study of cancer biology is an understanding
of how normal tissue differentiation is achieved. Three-dimen-
sional ECM culture models have highlighted the importance of
matrix compliance for tissue-specific differentiation and imply
that cells in 3D might respond differently to growth, polarity,
and death stimuli (O’Brien et al., 2002; Paszek and Weaver,
2004; Wang et al., 1998; Weaver et al., 2002). We found that
matrix compliance differs dramatically between 2D and 3D cul-
tures, and normal versus tumor tissue in vivo, and that faithful
recapitulation of normal tissue morphogenesis is favored by
matrix conditions with an elastic modulus that corresponds
with normal tissues in vivo. Our observations are consistentCANCER CELL : SEPTEMBER 2005
A R T I C L EFigure 6. Matrix stiffness induces integrin cluster-
ing to enhance GF-dependent ERK activation
and Rho-generated tension, increase growth,
and perturb tissue morphology
A: Cell force quantified by TFM in fibroblasts on
a FN gel, treated with vehicle or the ROCK inhib-
itor Y-27632.
B: Representative immunoblot and quantifica-
tion of immunoprecipitated Rhotekin-associ-
ated Rho (GTP-Rho) and total Rho (Rho), in fi-
broblasts on soft and stiff FN gels.
C: Cell force using TFM of vector control (Con-
trol) and V14Rho-expressing fibroblasts on soft
(450 Pa) and stiff (5600 Pa) FN gels.
D: Cell area of vector control (Control) and
V14Rho-expressing fibroblasts on soft and stiff
FN gels.
E: Confocal IF images of FAKpY397 (red) in control
or V14Rho-expressing fibroblasts.
F: Confocal IF images of β4 integrin (green), co-
stained with β-catenin (red), FAKpY397, vinculin
(red), actin (red), and nuclei (blue), in MEC col-
onies in a compliant (175 Pa) BM for 16 days,
expressing either a vector (Vector) or active Rho
(V14Rho) treated with vehicle or the MEK-1 in-
hibitor U0126.
G: Colony size of MECs expressing vector (Vec-
tor) or active Rho (V14Rho) treated with vehicle
or U0126, in BM for 16 days.
H: Total force (TFM) exerted by V14Rho MECs on
soft gels treated with vehicle or U0126.
I: Representative immunoblot of ROCK ex-
pressed in V14Rho MECs treated with vehicle
or U0126.
Results in G are mean ± SEM of three experi-
ments; A, C, and D represent z50 measure-
ments. *p % 0.05; **p % 0.01; ***p % 0.001.with the role shown for matrix compliance in smooth muscle
cell differentiation (Engler et al., 2004) and extend those findings
to incorporate the effect of matrix stiffness on multicellular epithe-
lial tissue morphogenesis. We also identified a plausible mecha-
nism for these effects by showing how matrix compliance can
influence cell fate by regulating Rho-generated cytoskeletal ten-
sion to induce FA assembly and enhance integrin-dependent GF-
induced activation of ERK. Moreover, we determined that some
transformed cells have altered tensional homeostasis, which
could partly explain why some malignant cells can grow andCANCER CELL : SEPTEMBER 2005survive in the absence of exogenous matrix tension (i.e., in sus-
pension), fail to undergo differentiation in compliant 3D ECMs,
and have elevated FAKpY397 in culture and in vivo (Lark et al.,
2005; McLean et al., 2004; Wang et al., 2000; Wozniak et al.,
2003). By illustrating how exogenous force and cytoskeletal
tension are integrated, and how they could cooperate to influ-
ence integrin adhesions and GF-dependent activation of ERK,
our studies offer a fresh perspective for understanding the mo-
lecular basis of tissue differentiation and tumor formation.
Adherent cells interrogate the physical properties of their249
A R T I C L EFigure 7. Growth factor signaling, Rho-generated contractility, FAs, and the malignant phenotype
A: Representative immunoblot of immunoprecipitated Rhotekin-associated Rho (GTP-Rho) and total Rho (Rho), in S-1 nonmalignant (S-1) and T4-2 malig-
nant (T4-2) MECs.
B: Confocal IF images of FAKpY397 (red) in 3D BM colonies of S-1 and T4-2 control (Control), and T4-2s expressing EGFP-tagged N19Rho (EGFP N19Rho;
green) or treated with the ROCK inhibitor (Y-27632).
C: Total force (TFM) on soft BM gels exerted by S-1 and control and N19Rho-expressing T4-2s, or T4-2s treated with Y-27632 or Blebbistatin.
D: Representative traction force maps of various MECs on soft BM gels.
E: Cell spreading quantified as cell area in S-1, and T4-2 control and N19Rho T4-2s on soft and stiff BM gels.
F: Confocal IF images of β4 integrin (green), β-catenin (red), and LN-5 (green), costained for nuclei (blue), in S-1 and control, MEK inhibitor-reverted (Rvt),
N19Rho-expressing, and Y-27632-treated T4-2 colonies.
G: Colony size of control (Control), MEK inhibitor-reverted (Rvt), N19Rho-expressing (N19Rho), and ROCK-inhibited (Y-27632) T4-2 MECs.
H: Cell proliferation measured as percent Ki-67 labeling in control (Control), MEK inhibitor-reverted (Rvt), N19Rho-expressing (N19Rho), and ROCK-inhibited
(Y-27632) T4-2 MECs colonies.250 CANCER CELL : SEPTEMBER 2005
A R T I C L Ethat integrins facilitate tumor metastasis and can influence ex-
I: Representative immunoblot of total and phospho-EGFR compared to E-cadherin in control (Control), N19Rho-expressing (N19Rho), and ROCK-inhibited
(Y-27632) T4-2 MEC colonies.
J: Representative immunoblot of total and phospho-ERK and ROCK compared to E-cadherin in control (T4-2) and phenotypically reverted (Rvt) T4-2
MEC colonies.
Results in G and H are mean ± SEM of three experiments of z200 measurements; C and E represent z50 measurements. ***p % 0.001. Colonies were in
BM for 12 days.
tagonize tumor invasion because it would promote the assem-Figure 8. Model of tensional homeostasis and force-dependent malignant
transformationECM and form integrin adhesions that reflect the compliance
of the matrix and the inherent activity of their contractile ma-
chinery (Bershadsky et al., 2003). We showed that matrix stiff-
ness drives FA assembly to modify GF signaling and cell phe-
notype by regulating ERK and Rho activity to modulate cell
contractility. Using matrices of defined compliance and an ex-
ogenous shear force, we showed that a force threshold exists
that favors integrin aggregation and FA assembly. Because we
found that integrin clustering precedes and is sufficient for ten-
sion-dependent ERK and Rho activity and FA assembly, our
data provide compelling evidence in support of the anisotropy
adhesion model. This model maintains that the biochemical re-
sponse of adhesions to cytoskeletal tension originates from the
stress-induced elastic deformation of the adhesion site, such
that the growth of FAs is mediated by the local density of pro-
teins within the junction via force-initiated interactions (Nicolas
et al., 2004).
Malignant transformation is characterized by a reactive
stroma, altered stromal-epithelial interactions, and changes in
integrins (Guo and Giancotti, 2004; Zahir et al., 2003). GivenCANCER CELL : SEPTEMBER 2005pression of the malignant phenotype (Wang et al., 1998; White
et al., 2004), it is important to understand how integrins be-
come altered to contribute to malignant transformation. We
found that oncogene-induced tumors and their adjacent
stroma are significantly stiffer than normal tissue and that mat-
rix rigidity clusters integrins to enhance GF-dependent ERK ac-
tivation and promotes growth and FA assembly through Rho-
dependent cytoskeletal tension. Yet, we also determined that
the aberrant morphological structures formed by GF-trans-
formed or V14Rho-expressing cells with elevated ERK- and
Rho-dependent cytoskeletal tension can be phenotypically
normalized by treatment with either a MEK or myosin II inhibi-
tor. Because inhibitor-mediated phenotypic reversion of these
aberrant morphologies was associated with reduced cell force
generation (cytoskeletal tension) and reduced ROCK expres-
sion, this implies that a functional regulatory circuit exists be-
tween integrins, ERK, Rho, and cytoskeletal tension to control
cell and tissue behavior. By showing that exogenous force and
endogenous force cooperate to regulate cell behavior through
FA assembly/stabilization, we maintain that the type of integrin
adhesion in a tumor may be more significant than the level of
integrins expressed (McLean et al., 2004).
Rho activity is frequently elevated in tumors (Fritz et al.,
1999), and ROCK can destabilize AJs (Sahai and Marshall,
2002) and promote tumor invasion and angiogenesis in vivo
(Croft et al., 2004; Fritz et al., 1999). Furthermore, patients with
inflammatory breast cancer who have elevated ROCK activity
show high levels of metastasis and have the worst prognosis
(Paszek and Weaver, 2004). Despite these data, the current
paradigm maintains that Rho is a tumor suppressor because it
promotes stable FAs that impede cell migration. According to
this model, the invasive phenotype of Ras-transformed cells
hinges upon their ability to downregulate ROCK and reduce
cell contractility to destabilize FAs and permit cell migration
(Sahai et al., 2001). Yet, most studies examining the role of Rho
in transformation have been conducted on tissue culture plas-
tic (highly stiff), which greatly enhances Rho activity, GF-depen-
dent ERK activation, FA formation, and cytoskeletal tension.
Given that balanced Rac and Rho activity is required for opti-
mal cell migration, culture conditions that elevate Rho-depen-
dent tension could distort experimental observations. By using
matrix conditions that match the compliance of normal and
transformed tissues in vivo, our data indicate that malignant
transformation likely precedes along an exogenous and endog-
enous force continuum. This paradigm implies that tissue ho-
meostasis is favored by a compliant matrix and low integrin-
ERK-Rho-cytoskeletal tension, whereas tumorigenic behavior
initiates when the matrix becomes chronically stiffer and/or in-
tegrin-ERK-Rho activity rises appreciably and remains elevated
for protracted periods of time. A highly stiff matrix or exceed-
ingly high integrin-ERK-Rho signaling would theoretically an-251
A R T I C L Ebly of multiple stable FAs. This model could explain why
MMTV-Ras and Myc mammary tumors typically form encapsu-
lated and highly rigid tumors that do not readily metastasize,
and why early passages of Ras-transformed fibroblasts form
abundant stress fibers with numerous FAs and fail to migrate
on tissue culture plastic, until ROCK levels decrease (Vial et
al., 2003).
In conclusion, ERK and Rho appear to be part of an integ-
rated mechanoregulatory circuit that functions to link physical
cues from the stromal ECM through integrin adhesions to mo-
lecular pathways that control cell growth and tissue phenotype.
A chronic increase in cytoskeletal tension, mediated by sus-
tained matrix stiffness (a prolonged injury or chronic inflamma-
tory response), or through elevated ERK activity (oncogene
amplification) if of sufficient magnitude and duration, could
drive the assembly/stabilization of FAs to enhance growth and
perturb tissue organization, thereby promoting malignant trans-
formation of a tissue.
Experimental procedures
Antibodies and reagents
The following antibodies were used: monoclonal (mAb) COL IV, CIV 22
(Dako); LN-5 α3 chain specific, BM165 (gift P. Marinkovich); β1-integrin,
TS2/16 (ATCC), AIIB2 and HUTS-4 and 21, β4 integrin, 3E1; α3 integrin,
P15B and α5 integrin, NKI-SAM-1 (Chemicon); E-cadherin, 36; Ki-67, 37;
and FAK, 77 (BD Transduction); α5 integrin, 5H10-27 (BD PharMingen);
talin, 8D4 and vinculin, VIN-11-5 (Sigma); and Src, 327 (Oncogene Res);
polyclonals to FAKpY397 and FAKpY861 (BioSource), activated SrcpY416 family
kinase, lyn, lck, and ERK, activated lynpY507 and lckpY505 and ERK (p44/
p42; Cell Signaling); fyn and yes (Santa Cruz Biotech); β-catenin (Sigma),
ROCK (AnaSpec) and actin, Alexa Fluor 488- or 594-conjugated Phalloidin
(Molecular Probes); rat, rabbit and mouse IgGs (Jackson Labs); Alexa Fluor
488 and 555-conjugated anti-mouse, rat, and rabbit IgGs (Molecular
Probes), HRP-conjugated rabbit and mouse secondary Abs (Amersham
Pharmacia).
ROCK inhibitor was Y-27632 (40 M; Calbiochem), and myosin inhibitor
was Blebbistatin (50 mM); MEK-1 inhibitors were PD 98059 and U0126
(12.5 M; BIOMOL).
Cell culture
The HMT3522 and MCF10A MECs and NIH 3T3 cells were maintained as
described (Debnath et al., 2003; Wang et al., 1998; Yeung et al., 2005).
Mouse manipulations
FVB-TgN (MMTV-c-myc, Her2/neu, and H-ras) mice were maintained in ac-
cordance with the guidelines of Laboratory Animal Research at the Univer-
sity of Pennsylvania. Once tumors formed (12–24 weeks), mice were sacri-
ficed, and the inguinal mammary glands were excised and analyzed.
Tissues were fixed in 4% paraformaldehyde, and paraffin sections were
stained with H&E for histopathological evaluation.
Gel manipulations
ECM-crosslinked PA gels were prepared and mechanically analyzed as de-
scribed (Reinhart-King et al., 2003). For more details, see the Supplemental
Experimental Procedures available with this article online.
Materials properties of tissues and natural gels
An electromechanical computer-controlled indenter comprised of a minia-
ture linear stepper motor (minimal displacement 0.0032 mm), force trans-
ducer (load capacity 1.47 N), and a linear variable displacement transducer
was used to measure the material stiffness of mammary tissue and ECM
gels. The tangent elastic modulus of the unconfined stress-strain curve
(slope) was calculated between 5% and 15% constant strain (Gefen et al.,
2003).252tfm
Images of cells on PA gels containing fluorescent beads were collected
before and after trypsinization using a Nikon Inverted Eclipse TE300 micro-
scope and a Photometric Cool Snap HQ camera (Roper Scientific). TFMs
were calculated based on differences in bead displacement induced by
substrate deformation and relaxation using a software analysis program
(Reinhart-King et al., 2003).
Shear force manipulations
Cells on FN-crosslinked PA (450 G#) gel-coated coverslips were subjected
to a centrifugal shear force (room temperature [RT]) and analyzed for mor-
phology, integrin adhesions, and FAK. Because the strain field increases
with radius from the center of the disk according to the equation τ =
0.800rO(ρω3), where τ is the shear stress exerted on a cell, ρ is the density,
 is the buffer viscosity, and ω is the rotational speed, the force applied to
each cell was calculated based upon its radial position on the disk and the
applied RPM. Cell attachment strength was assessed based upon the τ50,
which corresponds to the shear stress required to detach 50% of the ad-
hered cells (Shi and Boettiger, 2003). For more details, see the Supplemen-
tal Experimental Procedures.
Immunofluorescence
Cells were extracted by CSK buffer and fixed or directly fixed using 2%
paraformaldehyde (RT) or methanol (−20°C). Some cultures were embed-
ded in sucrose and frozen in Tissue-Tek OCT compound, and 20 m sec-
tions were immunostained. Paraffin-embedded tissue sections (4 m) were
subjected to antigen retrieval (citrate buffer) prior to immunostaining. All
samples were incubated with primary mAb followed by Alexa-conjugated
secondary Abs. Nuclei were counterstained with diaminophenylindole
(DAPI; Sigma). Cells were visualized using a Bio-Rad MRC 1024 laser scan-
ning confocal microscope attached to a Nikon Diaphot 200 microscope.
Images were recorded at 120× magnification.
Morphometric analysis
Cell area was calculated by tracing phase images of fixed cells, and colony
size was determined by tracing colony diameter of live colony images using
a Nikon Inverted Eclipse TE300 microscope and a Photometric Cool Snap
HQ camera (Roper Scientific) and ImagePro software (Yeung et al., 2005).
To quantify integrin adhesion size, Z-stacked images of integrin adhesions
were acquired using a Bio-Rad MRC 1024 confocal microscope, and
images were processed with a computer-based analysis package, Image-
Pro (Zajaczkowski et al., 2003), and statistically analyzed using a two-tailed
Student’s t test.
Proliferation
Cell proliferation was measured by calculating the percent Ki67-labeled nu-
clei (Weaver et al., 2002).
Quantification of integrin activity and cell adhesion
Cell adhesion was assessed using a fluorescence attachment assay (Zahir
et al., 2003), and integrin activity was quantified by immunoblotting (Tzima
et al., 2001).
Immunoblot analysis
Equal RIPA or Laemmli lysate was separated on SDS-PAGE gels, immu-
noblotted, and detected with an ECL system (Amersham).
Vector description
Myc-tagged V14RhoA and EGFP-tagged N19RhoA in LZRS-IRES-blastici-
din were used directly (Zahir et al., 2003). The constitutively active human
β1 integrin glycan wedge mutant G429N in pEF1/V5-His has been charac-
terized (Luo et al., 2004). V737N and G744N mutations were generated
using the QuikChange Site-Directed Mutagenesis Kit (Stratagene) from the
full-length human β1 integrin cDNA (gift of Z. Werb), and constructs were
fused by PCR to EGFP at the C terminus or expressed bicistronically with
EGFP in the Tet off system.
Ectopic gene expression
Retrovirus was produced in 293 or Phoenix ampho cells (G. Nolan), and
cells were selected using G418, puromycin, or blasticidin. TransfectionsCANCER CELL : SEPTEMBER 2005
A R T I C L Ewith wild-type β1 in pcDNA 3.1, G429N β1 integrin in pEF1/V5-His, and
EGFP in PRC CMV plasmid DNA were with Lipofectamine (Gibco BRL).
Rho GTPase activity
Cells were lysed in G protein buffer, and Rho GTPase activity was assayed
using purified GST-Rhotekin and a Rhotekin pulldown assay (Tzima et al.,
2001).
Supplemental data
The Supplemental Data include Supplemental Experimental Procedures,
five supplemental figures, and enlargements of Figures 1D, 2D, 3B, and 4C
and can be found with this article online at http://www.cancercell.org/cgi/
content/full/8/3/241/DC1/.
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